Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022
NEW YORK, April 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022
http://www.reportlinker.com/p0819456/Pharma-Leader-Series-Top-Pre-Filled-Injection-Device-Manufacturers-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Report Details
Pre-filled syringes - discover potentials and prospects of companies there
How are companies in the pre-filled syringe industry performing? Visiongain's report gives you data, analyses and discussions for producers of those drug delivery devices.
That new study lets you assess prominent companies in the pre-filled (ready-to-fill) syringe industry and market from 2012 to 2022.
There you find analytical profiles for leading companies - activities, outlooks and prospects:
• Becton, Dickinson & Co (BD)
• Gerresheimer
• Schott
• Datwyler
• West Pharmaceutical Services
• Ypsomed
• MGlas
• Nuova Ompi
• Stelmi
• Owen Mumford
• SHL Group
• Top emerging companies.
Also, see how device manufacturers compare, finding out how they compete from 2012.
Our investigation gives you business research and analysis, including revenue forecasts at world market, submarket, company and product level to 2022. You discover commercial data, predictions and discussions for companies and the market they operate in.
Where is pre-filled drug delivery heading? Many opportunities exist, especially for plastic syringes and ready-to-use containment of labile drugs and other complex pharmaceuticals.
What about applications? The incidence of diabetes and expansion of the home healthcare market, in particular, will stimulate demand for drug injection systems. Our study explains.
Greater use of biological drugs (biologics) and vaccines worldwide will raise demand for parenteral delivery systems. See how syringe manufacturers will seize opportunities in the pharmaceutical industry.
What about market needs? Medical injection systems giving improved clinical efficacy, safety and convenience will achieve commercial success this decade, our analysis shows.
We also analyse leading manufacturers of pen injectors, autoinjectors and pre-filled syringe components. You see opportunities for companies making plungers, needle shields and tip caps.
Suppliers and users of pre-filled injection devices will benefit from 2012. Our analytical survey shows you the potential for technological, clinical and commercial progress.
Revenue trends, discussions and results from our questionnaire-based survey
In visiongain's report you find historical revenues, sales forecasting, growth rates and market breakdowns. Also, you see discussions of companies and technologies, including the findings of our industry survey by questionnaire. You receive 97 tables and charts.
Ten ways Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022 helps you
In particular, the study gives you the following knowledge on the topic:
• Assess leading syringe producers, discovering their activities and outlooks
• Discover world market, submarket and product revenue forecasts to 2022
• Receive analyses of companies, seeing revenue forecasts to 2022
• View a comparative analysis of pre-filled syringe manufacturers
• See opinions from our survey, receiving views from companies
• Find existing revenues and operational data for leading companies
• Review technological developments, assessing trends and prospects
• Analyse prospects for applications of injection devices from 2012
• Investigate competition and opportunities influencing revenues
• Find out what will stimulate and restrain the industry and market.
There, you find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains.
We keep you informed about commercial trends and prospects for makers of those drug dispensing products, helping you to stay ahead.
Gain business research and analysis on pre-filled syringe specialists now
Our study is for everybody needing industry and market analyses for pre-filled syringes and related medical devices. You find data, trends and answers there. Please order that report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 Overview of Findings
1.2 Chapter Breakdown
1.3 Research and Analysis Methods
1.4 Scope of this Report
1.5 Terminology Used in this Report
2. An Introduction to Pre-Filled Syringe Manufacturing
2.1 Components of Pre-Filled Syringes
2.1.1 Pen Injectors and Autoinjectors
2.2 Demand for Pre-Filled Syringes
2.2.1 Advantages of Pre-Filled Syringes
2.3 The Future of Pre-Filled Syringes
2.3.1 The Pre-Filled Syringe Market 2010-2011
2.3.1.1 Regional Analysis of the Pre-Filled Syringe Market 2010-2011
2.3.2 The Pre-Filled Syringe Market 2012-2022
2.3.2.1 Pre-Filled Syringes vs. Other Drug Delivery Technologies: Market Forecast 2012-2022
2.3.3 Pen Injector and Autoinjector Submarket: Revenue Forecast 2012-2022
2.4 Leading Pre-Filled Syringe Manufacturers 2012
3. Becton, Dickinson & Co (BD)
3.1 Company Overview
3.2 Pre-Filled Syringe Products
3.2.1 BD Hypak Syringe Systems
3.2.2 BD Sterifill Syringe Systems
3.2.3 BD Soluvia
3.2.4 BD Uniject
3.2.5 BD Physioject
3.2.6 BD Pen Systems
3.2.7 BD Safety Systems
3.3 Recent Financial Performance
3.4 Strategy Analysis and Future Outlook
3.4.1 A Dominant Market Presence
3.4.2 Continued Expansion
3.4.3 Future Demand for BD's Products
3.4.4 BD Medical - Pharmaceutical Systems: Revenue Forecast 2012-2022
3.4.5 PegIntron: Revenue Forecast 2012-2022
3.4.6 Concluding Remarks
4. Gerresheimer
4.1 Company Overview
4.2 Pre-Filled Syringe Products
4.2.1 Ready-To-Fill (RTF) Syringes
4.2.2 ClearJect
4.2.3 Insulin Pens
4.3 Recent Financial Performance
4.3.1 RTF Manufacturing Expansion
4.3.2 Increased Interest in Plastics
4.3.3 Emerging Market Focus
4.4 Strategy Analysis and Future Outlook
4.4.1 Growing Demand for Plastics
4.4.2 Acquisitions for Expansion
4.4.2.1 Gerresheimer in Emerging Markets
4.4.3 Lantus: Revenue Forecast 2012-2022
4.4.4 Concluding Remarks
5. Schott
5.1 Company Overview
5.2 Pre-Filled Syringe Products
5.2.1 Forma 3s Glass Syringes
5.2.2 TopPac Polymer Syringes
5.2.3 InJentle Syringes
5.3 Recent Financial Performance
5.3.1 US Expansion
5.3.2 Asian Expansion
5.4 Strategy Analysis and Future Outlook
5.4.1 Diverse Syringe Portfolio
5.4.2 New Market Focus
5.4.3 Concluding Remarks
5.5 Company Insight
6. Datwyler
6.1 Company Overview
6.2 Pre-Filled Syringe Products
6.2.1 Omniflex Coating
6.2.2 Datwyler FirstLine
6.3 Recent Financial Performance
6.3.1 Global Expansion
6.3.2 Continued Product Development
6.4 Strategy Analysis and Future Outlook
6.4.1 Reinforcing its Presence in Asia
6.4.2 Meeting the Demands of the Pharmaceutical Industry
6.4.3 Datwyler Pharma Packaging: Revenue Forecast 2012-2022
6.4.4 Concluding Remarks
6.5 Company Insight
6.5.1 Datwyler's Recent Performance
6.5.2 Future Strategies
6.5.3 Outlook for the Pre-Filled Syringe Market
7. West Pharmaceutical Services
7.1 Company Overview
7.2 Pre-Filled Syringe Components and Products
7.2.1 Daikyo Crystal Zenith (CZ)
7.2.2 MixJect
7.2.3 ConfiDose Autoinjector
7.2.4 Éris Safety Syringe
7.3 Recent Financial Performance
7.3.1 Expanded Product Portfolio
7.4 Strategy Analysis and Future Outlook
7.4.1 Products Beyond Syringe Components
7.4.2 Investing to Expand
7.4.3 Concluding Remarks
7.5 Company Insight
7.5.1 West's Recent Performance
7.5.2 Future Strategies
7.5.3 Outlook for the Pre-Filled Syringe Market
8. Ypsomed
8.1 Company Overview
8.2 Ypsomed's Product Portfolio: Pen Injectors and Autoinjectors
8.2.1 YpsoPen
8.2.2 ServoPen
8.2.3 UnoPen
8.2.4 LyoTwist
8.2.5 Ypsomed Autoinjectors
8.3 Recent Financial Performance
8.3.1 A Move to Automation
8.3.2 The Importance of Diabetes
8.4 Strategy Analysis and Future Outlook
8.4.1 A Large and Growing Product Range
8.4.1.1 Focus Away From Injection Systems
8.4.2 A Partner for Big Pharma
8.4.2.1 Genotropin: Revenue Forecast 2012-2022
8.4.3 Delivery Devices: Revenue Forecast 2012-2022
8.4.4 Concluding Remarks
8.5 Company Insight
8.5.1 The Changing Demands of Customers
8.5.1.1 Recent Demand
8.5.1.2 Future Demand
8.5.2 Trends in Autoinjectors
9. Other Leading Pre-Filled Syringe Companies
9.1 MGlas
9.1.1 Company Overview
9.1.2 Pre-Filled Syringe Products
9.1.3 Merger Speculation
9.1.4 Company Analysis
9.2 Nuova Ompi
9.2.1 Company Overview
9.2.2 Pre-Filled Syringe Products
9.2.2.1 EZ-Fill
9.2.3 Company Analysis
9.2.4 Company Insight
9.2.4.1 Nuova Ompi's Recent Performance
9.2.4.2 Future Strategies
9.2.4.3 Outlook for the Pre-Filled Syringe Market
9.3 Stelmi
9.3.1 Company Overview
9.3.2 Pre-Filled Syringe Components
9.3.2.1 Rigid Needle Shields
9.3.3 Recent Financial Performance
9.3.4 Company Analysis
9.4 Owen Mumford
9.4.1 Company Overview
9.4.2 Pen Injectors and Autoinjectors
9.4.2.1 Autoject
9.4.2.2 Autopen
9.4.2.3 SimpleJect
9.4.3 Recent Financial Performance
9.4.3.1 Copaxone: Revenue Forecast 2012-2022
9.4.4 Company Analysis
9.4.4.1 Humira: Revenue Forecast 2012-2022
9.5 SHL Group
9.5.1 Company Overview
9.5.2 Pen Injectors and Autoinjectors
9.5.2.1 Molly Autoinjector
9.5.2.2 DAI Autoinjectors
9.5.3 Recent Performance
9.5.3.1 Expanding Manufacturing Facilities
9.5.4 Company Analysis
9.5.4.1 Aranesp: Revenue Forecast 2012-2022
10. Market Leaders: Product and Strategy Comparison of Companies
10.1 Competitor Analysis
10.1.1 Pre-Filled Syringes
10.1.2 Pen Injectors and Autoinjectors
10.2 Common Development Strategies
10.2.1 Emerging-Market Expansion
10.2.2 Biologics and Biosimilars
10.2.3 Safety Innovations
10.2.3.1 Competitors in Safety Products
10.2.3.2 Safety Syringes
10.2.4 Investment in Other Drug Delivery Technologies
10.3 Up and Coming Pre-Filled Syringe Manufacturers
10.3.1 Unilife
10.3.2 Revolutions Medical
10.4 Concluding Remarks
10.5 Company Survey
10.6 Company Details
List of Tables
Table 1.1 Currency Exchange Rates
Table 2.1 Pre-Filled Syringes Market by Sector, 2010-2011
Table 2.2 Pre-Filled Syringes Market: Overall Market and Submarket Revenue Forecasts, 2010-2022
Table 2.3 Drug Delivery Technologies Market by Sector, 2010
Table 2.4 Drug Delivery Technologies: Overall Market and Submarket Revenue Forecasts, 2010-2022
Table 2.5 Leading Pre-Filled Syringe and Related Technology Manufacturers, 2012
Table 3.1 BD: Company Revenue, 2006-2011
Table 3.2 BD Medical: Revenue by Segment, 2009-2011
Table 3.3 BD Medical - Pharmaceutical Systems: Revenue Forecast, 2010-2022
Table 3.4 PegIntron: Revenue Forecast, 2010-2022
Table 4.1 Gerresheimer: Employees by Division, 2010
Table 4.2 Gerresheimer: Revenue by Division, 2009 & 2010
Table 4.3 Lantus: Revenue Forecast, 2010-2022
Table 5.1 Schott: Revenue 2008-2010
Table 5.2 Schott Survey Results: Production Capacity and Customer Demands, 2012
Table 6.1 Datwyler Pharma Packaging: Employees by Country, 2011
Table 6.2 Datwyler: Revenue by Division, 2007-2010
Table 6.3 Datwyler Pharma Packaging: Revenue and EBIT, Half-Year 2010 & 2011
Table 6.4 Datwyler Pharma Packaging: Revenue Forecast, 2010-2022
Table 7.1 West Pharmaceutical Services: Revenue by Segment, 2008-2010
Table 7.2 West Delivery Systems: Revenue by Segment, 2008-2010
Table 8.1 Ypsomed: Group Companies, 2011
Table 8.2 Ypsomed: Major Pharmaceutical Partners, 2011
Table 8.3 Ypsomed: Revenue by Segment, 2009-2011
Table 8.4 Ypsomed: Half-Year Revenue by Segment, 2011 & 2012
Table 8.5 Genotropin: Revenue Forecast, 2010-2022
Table 8.6 Ypsomed Delivery Devices: Revenue Forecast, 2010-2022
Table 9.1 Stelmi: Revenue, 1999-2007
Table 9.2 Owen Mumford: Revenue, 2009 & 2010
Table 9.3 Copaxone: Revenue Forecast, 2010-2022
Table 9.4 Humira: Revenue Forecast, 2010-2022
Table 9.5 SHL Group: Pen Injectors and Autoinjectors, 2012
Table 9.6 Aranesp: Revenue Forecast, 2010-2022
Table 10.1 Glass Pre-Filled Syringes: Leading Product Comparisons, 2012
Table 10.2 Plastic Pre-Filled Syringes: Product Comparisons, 2012
Table 10.3 Pen Injectors: Product Comparisons, 2012
Table 10.4 Autoinjectors: Product Comparisons, 2012
Table 10.5 Leading Manufacturers: Emerging-Market Strategies
Table 10.6 Biological Drugs: World Market Forecast, 2010, 2016 & 2022
Table 10.7 Selected Pre-Filled Syringe Products Available for Biologics, 2012
Table 10.8 Insulin: World Market Forecast, 2010-2022
Table 10.9 Vaccine Inhalers Currently Under Development, 2012
Table 10.10 Other Drug Delivery Devices Offered by Leading Players, 2012
Table 10.11 Unilife: Revenue by Segment, 2009-2011
Table 10.12 BD: Key Facts, 2012
Table 10.13 Gerresheimer: Key Facts, 2012
Table 10.14 Schott: Key Facts, 2012
Table 10.15 MGlas: Key Facts, 2012
Table 10.16 Nuova Ompi: Key Facts, 2012
Table 10.17 Datwyler: Key Facts, 2012
Table 10.18 West: Key Facts, 2012
Table 10.19 Stelmi: Key Facts, 2012
Table 10.20 Ypsomed Key Facts, 2012
Table 10.21 Owen Mumford Key Facts, 2012
Table 10.22 SHL Group Key Facts, 2012
List of Figures
Figure 2.1 Pre-Filled Syringes Market by Sector, 2010-2011
Figure 2.2 Pre-Filled Syringes Market: Overall Revenue Forecast, 2010-2022
Figure 2.3 Drug Delivery Technologies Market by Sector, 2010
Figure 2.4 Drug Delivery Technologies: Market Forecast, 2010-2022
Figure 2.5 Drug Delivery Technologies: Submarket Shares, 2016
Figure 2.6 Drug Delivery Technologies: Submarket Shares, 2022
Figure 2.7 Pen Injectors and Autoinjectors Submarket: Revenue Forecast, 2010-2022
Figure 2.8 Other Pre-Filled Syringe Products Submarket: Revenue Forecast, 2010-2022
Figure 3.1 BD: Company Revenue, 2006-2011
Figure 3.2 BD Medical: Revenue by Segment, 2009-2011
Figure 3.3 BD Medical - Pharmaceutical Systems: Opportunities and Threats, 2012-2022
Figure 3.4 BD Medical - Pharmaceutical Systems: Revenue Forecast, 2010-2022
Figure 3.5 PegIntron: Revenue Forecast, 2010-2022
Figure 4.1 Gerresheimer: Employees by Division, 2010
Figure 4.2 Gerresheimer: Revenue by Division, 2009-2010
Figure 4.3 Gerresheimer: Opportunities and Threats, 2012-2022
Figure 4.4 Lantus: Revenue Forecast, 2010-2022
Figure 5.1 Schott: Revenue 2008-2010
Figure 5.2 Schott: Opportunities and Threats, 2012-2022
Figure 5.3 Schott Survey Results: Trends from the Pharmaceutical Industry
Figure 5.4 Schott Survey Results: Demands from the Market and Future Product Requirements
Figure 6.1 Datwyler Pharma Packaging: Employees by Country, 2011
Figure 6.2 Datwyler Pharma Packaging: Revenue, 2007-2010
Figure 6.3 Datwyler Pharma Packaging: Revenue and EBIT, Half-Year 2010 & 2011
Figure 6.4 Datwyler Pharma Packaging: Opportunities and Threats, 2012-2022
Figure 6.5 Datwyler Pharma Packaging: Revenue Forecast, 2010-2022
Figure 7.1 West Pharmaceutical Services: Revenue by Segment, 2008-2010
Figure 7.2 West Delivery Systems: Revenue by Segment, 2008-2010
Figure 7.3 West Pharmaceutical Services: Opportunities and Threats, 2012-2022
Figure 8.1 Ypsomed: Revenue by Segment, 2009-2011
Figure 8.2 Ypsomed: Half-Year Revenue by Segment, 2011 & 2012
Figure 8.3 Ypsomed Delivery Devices: Opportunities and Threats, 2012-2022
Figure 8.4 Genotropin: Revenue Forecast, 2010-2022
Figure 8.5 Ypsomed Delivery Devices: Revenue Forecast, 2010-2022
Figure 9.1 Stelmi: Revenue, 2001, 2004 & 2007
Figure 9.2 Owen Mumford: Revenue, 2009 & 2010
Figure 9.3 Copaxone: Revenue Forecast, 2010-2022
Figure 9.4 Humira: Revenue Forecast, 2010-2022
Figure 9.5 Aranesp: Revenue Forecast, 2010-2022
Figure 10.1 Biological Drugs: World Market Forecast, 2010, 2016 & 2022
Figure 10.2 Insulin: World Market Forecast, 2010-2022
Figure 10.3 Unilife: Revenue by Segment, 2009-2011
Companies Listed
Abbott Laboratories
Alfamatic (part of the Stevanato Group)
American Stelmi
Amgen
Amylin Pharmaceuticals
Antares Pharma
B. Braun
Baxter BioPharma Solutions (part of Baxter International)
Baxter International
Bayer
Becton, Dickinson & Co (BD)
Biogen Idec
Boehringer Ingelheim
Cambridge Consultants
Carmel Pharma
Catalent
CeifiT
Daikyo Seiko
Datwyler Group
Diagenode
Disetronic Group (now part of Roche)
Dongbao
DS WorldMed
Eisai
Elan
Eli Lilly
European Medicines Agency (EMA)
Food and Drug Administration (FDA) [US]
Genentech (now part of Roche)
Generex
Gerresheimer
Gerresheimer Bunde (subsidiary of Gerresheimer)
GSK
Harvard University
Inhibitex
Insulet
J&J
La Model (now part of West)
Ligocyte Pharmaceuticals
Medical Glass (part of the Stevanato Group)
MedImmune
Medimop Medical Projects (now part of West)
MedPro Safety Products
Merck & Co.
Merck Serono (also Merck KGaA)
MG Sterile Products
MGlas
MGlas Scandinavia (formerly Pharmapack Packaging Systems)
Ministry of Health [Brazil]
Momenta
Mylan
Naigai Glass Industry Co
Natco
Nektar Therapeutics
Nippon Zeon Co
Novartis
Novo Nordisk
Nuova Ompi (part of the Stevanato Group)
Nycomed (now part of Takeda)
Ompi of America (part of the Stevanato Group)
Optrel (subsidiary of Spami)
Otsuka Pharmaceutical
Owen Mumford
PATH
Pertinax (now part of SHL Group)
Pfizer
Pharma-Pen (now part of West)
PharmaPraxis
Pharmasset
Pharmstandard
Plastef Investissements
Polfa Tarchomin
Revolutions Medical
Roche
Rumpler Technologies
Safety Syringes
Sandoz
Sanofi
Sanofi Pasteur (part of Sanofi)
Schering-Plough (now part of Merck & Co.)
Schott
SHL Group
Spami (part of the Stevanato Group)
Stelmi
Stelmi Asia
Stevanato Group
Taisei Kako Co
Teva Pharmaceutical Industries
tip-top
Tonghua Dongbao Pharmaceutical Co
Unilife
University of Colorado
US Agency for International Development (USAID)
Vedat (now part of Gerresheimer)
Vertex Pharmaceuticals
Vetter Pharma
Watson Pharmaceuticals
West Company Mexico (subsidiary of West)
West Pharmaceutical Services
Ypsomed and its subsidiaries:
DiaExpert
feelfree
Ypsomed AB
Ypsomed BV
Ypsomed Distribution
Ypsomed GmbH
Ypsomed India Private Ltd
Ypsomed Ltd
Ypsomed SAS
Ypsotec
Ypsotec s.r.o.
Zhejiang Xinkang Pharmaceutical Glass Co
To order this report:
In Vitro Diagnostic Industry: Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article